- Home
- ARQQ vs EGRX Comparison
ARQQ vs EGRX Comparison
Compare ARQQ & EGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQQ
- EGRX
- Stock Information
- Founded
- ARQQ 2017
- EGRX 2007
- Country
- ARQQ United Kingdom
- EGRX United States
- Employees
- ARQQ N/A
- EGRX N/A
- Industry
- ARQQ Computer Software: Prepackaged Software
- EGRX Biotechnology: Pharmaceutical Preparations
- Sector
- ARQQ Technology
- EGRX Health Care
- Exchange
- ARQQ Nasdaq
- EGRX Nasdaq
- Market Cap
- ARQQ 50.0M
- EGRX 50.7M
- IPO Year
- ARQQ N/A
- EGRX 2014
- Fundamental
- Price
- ARQQ $4.47
- EGRX $2.14
- Analyst Decision
- ARQQ Strong Buy
- EGRX
- Analyst Count
- ARQQ 1
- EGRX 0
- Target Price
- ARQQ $50.00
- EGRX N/A
- AVG Volume (30 Days)
- ARQQ 100.3K
- EGRX 321.6K
- Earning Date
- ARQQ 11-19-2024
- EGRX 11-12-2024
- Dividend Yield
- ARQQ N/A
- EGRX N/A
- EPS Growth
- ARQQ N/A
- EGRX N/A
- EPS
- ARQQ N/A
- EGRX 0.91
- Revenue
- ARQQ $740,000.00
- EGRX $257,551,000.00
- Revenue This Year
- ARQQ $341.56
- EGRX N/A
- Revenue Next Year
- ARQQ $274.91
- EGRX N/A
- P/E Ratio
- ARQQ N/A
- EGRX $2.35
- Revenue Growth
- ARQQ N/A
- EGRX N/A
- 52 Week Low
- ARQQ $3.72
- EGRX $1.80
- 52 Week High
- ARQQ $23.00
- EGRX $14.78
- Technical
- Relative Strength Index (RSI)
- ARQQ 35.45
- EGRX 20.52
- Support Level
- ARQQ $4.35
- EGRX $3.76
- Resistance Level
- ARQQ $6.00
- EGRX $4.11
- Average True Range (ATR)
- ARQQ 0.81
- EGRX 0.43
- MACD
- ARQQ -0.14
- EGRX -0.13
- Stochastic Oscillator
- ARQQ 17.63
- EGRX 11.07
About ARQQ Arqit Quantum Inc.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology which makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. Arqit delivers its symmetric key agreement technology via its QuantumCloud. Its product, QuantumCloud, enables any device to download a lightweight software agent, which can create keys in partnership with any other device. The firm operates in one segment that is, the provision of cybersecurity services via satellite and terrestrial platforms. Key revenue comes from the UK.
About EGRX Eagle Pharmaceuticals Inc.
Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.